The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Binding of small molecules to an adaptive protein–protein interface
Open accessAbstract
Understanding binding properties at protein–protein interfaces has been limited to structural and mutational analyses of natural binding partners or small peptides identified by phage display. Here, we present a high-resolution analysis of a nonpeptidyl small molecule, previously discovered by medicinal chemistry [Tilley, J. W., et al . (1997) J. Am. Chem. Soc. 119, 7589–7590], which binds to the cytokine IL-2. The small molecule binds to the same site that binds the IL-2 α receptor and buries into a groove not seen in the free structure of IL-2. Comparison of the bound and several free structures shows this site to be composed of two subsites: one is rigid, and the other is highly adaptive. Thermodynamic data suggest the energy barriers between these conformations are low. The subsites were dissected by using a site-directed screening method called tethering, in which small fragments were captured by disulfide interchange with cysteines introduced into IL-2 around these subsites. X-ray structures with the tethered fragments show that the subsite-binding interactions are similar to those observed with the original small molecule. Moreover, the adaptive subsite tethered many more compounds than did the rigid one. Thus, the adaptive nature of a protein–protein interface provides sites for small molecules to bind and underscores the challenge of applying structure-based design strategies that cannot accurately predict a dynamic protein surface.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Kunkel, T. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.488 · Cited by 7,206
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,964
The finer things in X-ray diffraction data collection
Pflugrath, J. W. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744499900935x · Cited by 1,244
Structure and expression of a cloned cDNA for human interleukin-2
Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R., & Hamuro, J. (1983) · Nature · doi:10.1038/302305a0 · Cited by 1,182
Convergent Solutions to Binding at a Protein-Protein Interface
DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672
Self-citationFunctional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å
Livnah, O., Stura, E. A., Johnson, D. L., Middleton, S. A., Mulcahy, L. S., Wrighton, N. C., Dower, W. J., Jolliffe, L. K., & Wilson, I. A. (1996) · Science · doi:10.1126/science.273.5274.464 · Cited by 588
Molecular cloning of cDNA encoding human interleukin-2 receptor
Nikaido, T., Shimizu, A., Ishida, N., Sabe, H., Teshigawara, K., Maeda, M., Uchiyama, T., Yodoi, J., & Honjo, T. (1984) · Nature · doi:10.1038/311631a0 · Cited by 565
Protein−Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis
Stites, W. E. (1997) · Chemical Reviews · doi:10.1021/cr960387h · Cited by 491
Site-directed ligand discovery
Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9367 · Cited by 466
Self-citationMultiple diverse ligands binding at a single protein site: A matter of pre‐existing populations
Ma, B., Shatsky, M., Wolfson, H. J., & Nussinov, R. (2002) · Protein Science · doi:10.1110/ps.21302 · Cited by 420
Molecular cloning of human interleukin 2 cDNA and its expression inE. coli
Devos, R., Plaetinck, G., Cheroutre, H., Simons, G., Degrave, W., Tavernier, J. H., Remaut, E., & Fiers, W. C. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.13.4307 · Cited by 313
Inhibition of Protein−Protein Association by Small Molecules: Approaches and Progress
Toogood, P. L. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010468s · Cited by 281
Bursavich, M. G., & Rich, D. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010425b · Cited by 208
In situ assembly of enzyme inhibitors using extended tethering
Erlanson, D. A., Lam, J. W., Wiesmann, C., Luong, T. N., Simmons, R. L., DeLano, W. L., Choong, I. C., Burdett, M. T., Flanagan, W. M., Lee, D., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt786 · Cited by 203
Self-citationKrieger, M., Kay, L. M., & Stroud, R. M. (1974) · Journal of Molecular Biology · doi:10.1016/0022-2836(74)90388-x · Cited by 202
Structural Plasticity in a Remodeled Protein-Protein Interface
Atwell, S., Ultsch, M., De Vos, A. M., & Wells, J. A. (1997) · Science · doi:10.1126/science.278.5340.1125 · Cited by 180
Self-citationProtein–protein interfaces: mimics and inhibitors
Cochran, A. G. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(01)00262-9 · Cited by 149
Tilley, J., Chen, L., Fry, D. C., Emerson, S. D., Powers, G. D., Biondi, D. A., Varnell, T. A., Trilles, R. V., Guthrie, R. W., Mennona, F. A., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja970702x · Cited by 129
Sauvé, K., Nachman-Clewner, M., Spence, C. L., Bailon, P., Campbell, E., Tsien, W. H., Kondas, J. A., Hakimi, J., & Ju, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4636 · Cited by 100
Response : Unraveling the Structure of IL-2
McKay, D. (1992) · Science · doi:10.1126/science.257.5068.412 · Cited by 84
Zurawski, S., Vega, F., Doyle, E. L., Huyghe, B. G., Flaherty, K. M., McKay, D., & Zurawski, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06206.x · Cited by 82
Pan, B., Li, B., Russell, S. J., Tom, J., Cochran, A. G., & Fairbrother, W. J. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5370 · Cited by 72
Borthwick, A. D., Crame, A. J., Ertl, P. F., Exall, A. M., Haley, T. M., Hart, G. J., Mason, A. M., Pennell, A. M. K., Singh, O. M. P., Weingarten, G. G., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0102203 · Cited by 71
The Solution Structure of the F42A Mutant of Human Interleukin 2
Mott, H. R., BAINES, B. S., Hall, R. M., Cooke, R. M., Driscoll, P. C., Weir, M. P., & Campbell, I. D. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.0194 · Cited by 48
Deinum, J., Gustavsson, L., Gyzander, E., Kullman-Magnusson, M., Edström, Å., & Karlsson, R. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5454 · Cited by 46
Cited by
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Self-citationSmall-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
Self-citationSmall molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
The SCF ubiquitin ligase: insights into a molecular machine
Cardozo, T., & Pagano, M. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1471 · Cited by 1,114
Advances in covalent drug discovery
Boike, L., Henning, N. J., & Nomura, D. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00542-z · Cited by 823
Metadata
- Authors
- Arkin, M. R., Randal, M., DeLano, W. L., Hyde, J., Luong, T. N., Oslob, J. D., Raphael, D. R., Taylor, L., Wang, J., McDowell, R. S., Wells, J. A., & Braisted, A. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-02-11
- Volume
- 100
- Issue
- 4
- Pages
- 1603-1608
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2096454260
- Cited by
- 375
- References
- 26
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.